Markets:

Overview

News

Currencies

International

Treasuries

Cytokinetics, Incorporated - Common Stock (NQ:CYTK)

65.67 -0.47 (-0.71%)

Streaming Delayed Price Updated: 12:25 PM EDT, Apr 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cytokinetics, Incorporated - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Here's How Much $100 Invested In Cytokinetics 10 Years Ago Would Be Worth Today ↗

March 15, 2024

Via Benzinga

7 Biotech Stocks to Buy as Sector Rotation Ramps Up ↗

March 13, 2024

With digital innovation possibly getting overextended, now’s the time to consider biotech stocks for an incoming rotation.

Via InvestorPlace

Super Micro, Deckers To Join S&P 500 Index ↗

March 01, 2024

They'll replace Whirlpool and Zions Bancorp on March 18.

Via Investor's Business Daily

Topics Stocks

Unpacking the Latest Options Trading Trends in Cytokinetics ↗

February 28, 2024

Via Benzinga

Here's How Much $1000 Invested In Cytokinetics 10 Years Ago Would Be Worth Today ↗

February 27, 2024

Via Benzinga

Earnings Scheduled For February 27, 2024 ↗

February 27, 2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.

Via Benzinga

Here's How Much $1000 Invested In Cytokinetics 5 Years Ago Would Be Worth Today ↗

February 09, 2024

Via Benzinga

Here's How Much $100 Invested In Cytokinetics 5 Years Ago Would Be Worth Today ↗

February 02, 2024

Via Benzinga

2 Biotechs That Could Get Bought Out in 2024 ↗

January 03, 2024

These two biotechs have been frequent visitors to the buyout-rumor mill and for good reason.

Via The Motley Fool

Overbought, Overextended - What's The Buzz In S&P 500 Now? ↗

February 14, 2024

Here are the red flags you need to be aware of in this current market and the directional bias for the long-term, swing and immediate term.

Via Talk Markets

Topics Stocks

3 Biotech Stocks to Buy for the Next Bull Run: February 2024 ↗

February 08, 2024

These are the biotech stocks to buy that you must have on your watchlist for the coming bull run. It could get started as soon as this month.

Via InvestorPlace

How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month ↗

February 08, 2024

Cytokinetics is looking to take on Bristol Myers Squibb in treating a heart disease.

Via Investor's Business Daily

Banco Santander, Lloyds Banking And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

February 05, 2024

U.S. stock futures were lower this morning, with the Dow futures falling over 100 points on Monday. Shares of Banco Santander, S.A. (NYSE: SAN) shares fell sharply during today’s pre-market trading.

Via Benzinga

Topics Stocks

3 Healthcare Stocks at 52-Week Lows: Buy or Bye? ↗

January 26, 2024

Investors should consider picking up these healthcare stocks at 52-week lows to benefit from their potential rebound.

Via InvestorPlace

Biotech Playbook: Small Caps Show Momentum Peaking During ↗

January 15, 2024

The momentum of selected stocks was strong up until early January was encouraging but we need less volatility in period ahead to conform a new bull market.

Via Talk Markets

10 Health Care Stocks With Whale Alerts In Today's Session ↗

January 15, 2024

Via Benzinga

Cytokinetics' Heart Drug Is A Multi-Billion Dollar Opportunity By 2032 Despite Novartis Setback: Analyst ↗

January 12, 2024

Novartis halts pursuit of Cytokinetics acquisition, impacting promising heart drug. Analysts estimate $3.6 billion sales for Cytokinetics' cardiomyopathy drug by 2032. Still lead drug aficamten viewed...

Via Benzinga

Novartis Retreats From Cytokinetics Deal, Dashing Hopes For Multi-Billion Dollar Acquisition ↗

January 11, 2024

Novartis AG (NYSE: NVS) has decided to step back from pursuing the Cytokinetics Inc (NASDAQ: CYTK) acquisition, dealing a blow to the potential deal with the

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 11, 2024

Via Benzinga

Aspen Aerogels Issues Business Update, Joins Plug Power, SunPower And Other Big Stocks Moving Lower On Thursday ↗

January 11, 2024

U.S. stocks traded lower, with the Dow Jones index falling over 150 points on Thursday. Shares of Aspen Aerogels, Inc. (NYSE: ASPN) fell sharply during Thursday’s session after the company issued a...

Via Benzinga

Topics Stocks

Bullish Continuation In '24? 3 Market Areas To Watch ↗

January 10, 2024

This article discusses 3 market areas that should outperform dramatically over the next 12 months...

Via Talk Markets

What's Been Happening With Cytokinetics Stock? ↗

January 09, 2024

Cytokinetics, Incorporated (NASDAQ: CYTK) shares are trading lower on Tuesday, pulling back from Monday strength.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

January 09, 2024

Via Benzinga

Why Is Heart Failure Drug-Focused Cytokinetic Stock Trading Higher Today? ↗

January 08, 2024

Cytokinetics Inc (NASDAQ: CYTK) shares are trading higher after a report on potential takeover talks with Novartis AG (NYSE: NVS).

Via Benzinga

Cytokinetics Rockets 14% As Novartis Reportedly Nears A Buyout Deal ↗

January 08, 2024

The company is working on a treatment for a disease that can lead to heart failure.

Via Investor's Business Daily

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 08, 2024

Via Benzinga

CACI International To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Friday ↗

January 05, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

January 04, 2024

Via Benzinga

7 Stocks Primed for a Spectacular Comeback in 2024 ↗

January 03, 2024

Although the usual suspects may carry confidence, these underappreciated comeback stocks might deliver the goods in 2024.

Via InvestorPlace

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗

December 29, 2023

Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention.

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.